Abstract
In this chapter, we will summarize the data obtained from the analysis in previous chapters. We will define the criteria for the credibility of the connection of the viruses considered in this review with atherosclerosis and related diseases and will consider the principles of organization of studies in this field.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rogers KC, Wallace JP, Foster SL, Finks SW. Annual influenza vaccination: offering protection beyond infection. South Med J. 2012;105:379–86.
Grau AJ, Urbanek C, Palm F. Common infections and the risk of stroke. Nat Rev Neurol. 2010;6:681–94.
Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9: 601–10.
Lang PO, Mendes A, Socquet J, Assir N, Govind S, Aspinall R. Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging. 2012;7:55–64.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kutikhin, A., Brusina, E., Yuzhalin, A.E. (2013). Summary: Are We There Yet?. In: Viruses and Atherosclerosis. SpringerBriefs in Immunology, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8863-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8863-7_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8862-0
Online ISBN: 978-1-4614-8863-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)